Boeing rebounds in 2024 with increased 737 MAX production, exceeding Q4 revenue forecasts. Click here to read an analysis of BA stock now.

Ultragenyx's strong revenue growth, diverse streams, and late-stage pipeline make it a standout in rare disease and gene ...